hat
Konstitiyan yo te panse yo dwe responsab pou efè yo anti-enflamatwa nan Claw Dyab la (tubèrkul cheche segondè yo) se glikozid iridoid, patikilyèman harpagosid (trans-cinnamoyl harpagid) ki gen ladan ti kantite nan trans-coumaroyl gita sou kote, procumbent, ak plant sterol. Britanik Herbal Pharmacopoeia a rekonèt Claw Dyab la tankou li te gen analgesic, pwopriyete sedatif ak dyurèz. Pifò syans enplike itilizasyon kwonik la, olye ke tretman egi nan doulè. Sa a dwòg èrbal tou se ofisyèl nan Ewopeyen an Pharmacopoeia ak yon eleman nan yon nimewo nan preparasyon OTC ak sipleman dyetetik pou reklamasyon li yo anti-rimatism.
eng
The constituents thought to be responsible for the anti-inflammatory effects of Devil's Claw (dried secondary tubers) are iridoid glycosides, particularly harpagoside (trans-cinnamoyl harpagide) including small amounts of trans-coumaroyl harp aside, procumbent, and plant sterols. The British Herbal Pharmacopoeia recognizes Devil's Claw as having analgesic, sedative and diuretic properties. Most studies involve the chronic use, rather than acute treatment of pain. This herbal drug is also official in the European Pharmacopoeia and a component of a number of OTC preparations and dietary supplements for its claimed anti-rheumatic effects.